Literature DB >> 11145231

Niosomes and polymeric chitosan based vesicles bearing transferrin and glucose ligands for drug targeting.

C Dufes1, A G Schätzlein, L Tetley, A I Gray, D G Watson, J C Olivier, W Couet, I F Uchegbu.   

Abstract

PURPOSE: To prepare polymeric vesicles and niosomes bearing glucose or transferrin ligands for drug targeting.
METHODS: A glucose-palmitoyl glycol chitosan (PGC) conjugate was synthesised and glucose-PGC polymeric vesicles prepared by sonication of glucose-PGC/cholesterol. N-palmitoylglucosamine (NPG) was synthesised and NPG niosomes also prepared by sonication of NPG/ sorbitan monostearate/ cholesterol/ cholesteryl poly-24-oxyethylene ether. These 2 glucose vesicles were incubated with colloidal concanavalin A gold (Con-A gold), washed and visualised by transmission electron microscopy (TEM). Transferrin was also conjugated to the surface of PGC vesicles and the uptake of these vesicles investigated in the A431 cell line (over expressing the transferrin receptor) by fluorescent activated cell sorter analysis.
RESULTS: TEM imaging confirmed the presence of glucose units on the surface of PGC polymeric vesicles and NPG niosomes. Transferrin was coupled to PGC vesicles at a level of 0.60+/-0.18 g of transferrin per g polymer. The proportion of FITC-dextran positive A431 cells was 42% (FITC-dextran solution), 74% (plain vesicles) and 90% (transferrin vesicles).
CONCLUSIONS: Glucose and transferrin bearing chitosan based vesicles and glucose niosomes have been prepared. Glucose bearing vesicles bind Con-A to their surface. Chitosan based vesicles are taken up by A431 cells and transferrin enhances this uptake.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11145231     DOI: 10.1023/a:1026422915326

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.

Authors:  W M Pardridge; R J Boado; C R Farrell
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

2.  Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.

Authors:  T Higashi; N Tamaki; T Honda; T Torizuka; T Kimura; T Inokuma; G Ohshio; R Hosotani; M Imamura; J Konishi
Journal:  J Nucl Med       Date:  1997-09       Impact factor: 10.057

3.  Construction of transferrin-coated liposomes for in vivo transport of exogenous DNA to bone marrow erythroblasts in rabbits.

Authors:  J C Stavridis; G Deliconstantinos; M C Psallidopoulos; N A Armenakas; D J Hadjiminas; J Hadjiminas
Journal:  Exp Cell Res       Date:  1986-06       Impact factor: 3.905

4.  Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins.

Authors:  G E Davies; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

5.  Application of synthetic alkyl glycoside vesicles as drug carriers. I. Preparation and physical properties.

Authors:  H Kiwada; H Niimura; Y Fujisaki; S Yamada; Y Kato
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-02       Impact factor: 1.645

6.  Modified aminoacyl-tRNA. II. A general method for the preparation of acylaminoacyl-tRNA.

Authors:  Y Lapidot; N de Groot; I Fry-Shafrir
Journal:  Biochim Biophys Acta       Date:  1967-09-26

7.  Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting.

Authors:  M Monsigny; A C Roche; P Midoux
Journal:  Biol Cell       Date:  1984       Impact factor: 4.458

8.  Polymeric chitosan-based vesicles for drug delivery.

Authors:  I F Uchegbu; A G Schätzlein; L Tetley; A I Gray; J Sludden; S Siddique; E Mosha
Journal:  J Pharm Pharmacol       Date:  1998-05       Impact factor: 3.765

9.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.

Authors:  F Yuan; M Leunig; S K Huang; D A Berk; D Papahadjopoulos; R K Jain
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

10.  Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse.

Authors:  I F Uchegbu; J A Double; J A Turton; A T Florence
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

View more
  10 in total

1.  The effect of chain length on protein solubilization in polymer-based vesicles (polymersomes).

Authors:  Veena Pata; Nily Dan
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

2.  Preparation of Zein-Based Nanoparticles: Nanoprecipitation versus Microfluidic-Assisted Manufacture, Effects of PEGylation on Nanoparticle Characteristics and Cellular Uptake by Melanoma Cells.

Authors:  Jitkasem Meewan; Sukrut Somani; Jamal Almowalad; Partha Laskar; Margaret Mullin; Graeme MacKenzie; Swapnil Khadke; Yvonne Perrie; Christine Dufès
Journal:  Int J Nanomedicine       Date:  2022-06-29

3.  Swellable microparticles as carriers for sustained pulmonary drug delivery.

Authors:  Ibrahim M El-Sherbiny; Shayna McGill; Hugh D C Smyth
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

4.  Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles.

Authors:  Christine Dufes; Jean-Marc Muller; William Couet; Jean-Christophe Olivier; Ijeoma F Uchegbu; Andreas G Schätzlein
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 5.  Surface charge, glycocalyx, and blood-brain barrier function.

Authors:  Fruzsina R Walter; Ana R Santa-Maria; Mária Mészáros; Szilvia Veszelka; András Dér; Mária A Deli
Journal:  Tissue Barriers       Date:  2021-05-18

6.  Both FA- and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution.

Authors:  Zhenqing Hou; Chuanming Zhan; Qiwei Jiang; Quan Hu; Le Li; Di Chang; Xiangrui Yang; Yixiao Wang; Yang Li; Shefang Ye; Liya Xie; Yunfeng Yi; Qiqing Zhang
Journal:  Nanoscale Res Lett       Date:  2011-10-25       Impact factor: 4.703

Review 7.  Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles.

Authors:  Sara Salatin; Ahmad Yari Khosroushahi
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

8.  ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

Authors:  Xinyi Xu; Yuji Wang; Jianhui Wu; Xi Hu; Haimei Zhu; Xiaoyi Zhang; Yaonan Wang; Lin Gui; Ming Zhao; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2017-06-13

Review 9.  Challenges and Opportunities of Nanotechnology as Delivery Platform for Tocotrienols in Cancer Therapy.

Authors:  Geetha Maniam; Chun-Wai Mai; Mohd Zulkefeli; Christine Dufès; Doryn Meam-Yee Tan; Ju-Yen Fu
Journal:  Front Pharmacol       Date:  2018-11-26       Impact factor: 5.810

10.  Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid-Polymer Hybrid Nanoparticles.

Authors:  Intouch Sakpakdeejaroen; Sukrut Somani; Partha Laskar; Margaret Mullin; Christine Dufès
Journal:  Int J Nanomedicine       Date:  2021-04-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.